Articles tagged with: ASH 2012 Daily Update
Tuesday was the final day of this year’s American Society of Hematology (ASH) meeting, which took place in Atlanta. The meeting concluded in the morning with a series of oral presentation sessions held simultaneously.
Three of the morning sessions focused on the biology of multiple myeloma as well as preclinical and clinical studies of treatment options for multiple myeloma patients.
This update will summarize the research presented during the session that focused on myeloma treatment options. In addition, it will summarize results from an important late-breaking study of pomalidomide that …
Monday was the third and next-to-last day of the 2012 American Society of Hematology (ASH) annual meeting.
It also was the busiest day of the meeting in regard to myeloma-related research.
The day ended with a poster session in the evening that featured over 1000 posters displayed throughout a large conference hall. More than a hundred of the posters reported on the results of myeloma-related research.
Compared to the research summarized during oral presentations, the findings in poster summaries generally are in earlier stages of development. They may involve laboratory …
This year’s American Society of Hematology (ASH) meeting, which is taking place in Atlanta, came to a close earlier today. However, yesterday, the third day of the meeting, was packed with myeloma-related presentations.
Given the number of myeloma presentations made yesterday, The Beacon will summarize the four most important of yesterday’s oral presentation sessions as well as a number of the most important poster presentations in updates such as this one. Summaries of the first three key oral presentation sessions were published yesterday and earlier today. This update covers presentations …
We continue to report the latest myeloma-related findings from this year’s American Society of Hematology (ASH) meeting, which has come to a close in Atlanta. Yesterday was the third day of the meeting and featured the most myeloma-related presentations in a given day.
Yesterday, there were nearly 50 myeloma-related talks given during 11 oral presentation sessions. The Beacon will therefore summarize presentations from the four most important sessions in updates such as this one.
This update covers presentations from the third of the four key oral presentation sessions. Updates published …
This year’s American Society of Hematology (ASH) meeting continues in Atlanta. Yesterday was the third day of the meeting and the busiest day in terms of myeloma-related presentations. It was packed full of both oral and poster presentations.
There were so many myeloma-related talks given yesterday that many of them were held simultaneously. The Beacon will therefore summarize presentations from the four most important sessions in updates such as this one.
This update covers presentations from the second of the four key oral presentation sessions. An update published yesterday covers …